Identification of Adverse Drug Events The Use of ICD-10 Coded Diagnoses in Routine Hospital Data

被引:41
作者
Stausberg, Juergen [1 ]
Hasford, Joerg [1 ]
机构
[1] Univ Munich, Inst Med Informat Verarbeitung Biometrie & Epidem, D-81377 Munich, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2010年 / 107卷 / 03期
关键词
PATIENT SAFETY;
D O I
10.3238/arztebl.2010.0023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Adverse drug events (ADE) are a common cause of hospital admission as well as a common complication of inpatient care. The current reporting systems in Germany are of only limited use for the identification of ADE. The aim of this study is to examine the potential usefulness of ICD-10 coded diagnoses in routine hospital data for the identification of ADE. Methods: The common, major manifestations of ADE were mapped to the ICD-10-GM, and categories in the ICD-10-GM for which a possible causal relationship with medications is explicitly mentioned were included as well. A total of 505 relevant ICD-10-GM codes were identified. An evaluation was carried out on the basis of an aggregated data set from eleven million inpatients treated in 2006. Results: 0.7% of hospital admissions were revealed by routine data to be causally related to the administration of a drug. In 5.3% of admissions, there was at least a reason to suspect such a causal relation. Furthermore, one of the 505 relevant codes was found to be present in 9.0% of the secondary diagnoses. Conclusions: The available ICD-10-GM codes for manifestations of ADE are used in routine hospital data in Germany. Their usefulness for the identification of ADE should be better exploited. Our results and other relevant published literature imply that this procedure will result in both false-positive and false-negative findings, which will have to be taken into account as well.
引用
收藏
页码:23 / U10
页数:8
相关论文
共 20 条
  • [1] [Anonymous], 2007, AG PAT 2007
  • [2] INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I
    BRENNAN, TA
    LEAPE, LL
    LAIRD, NM
    HEBERT, L
    LOCALIO, AR
    LAWTHERS, AG
    NEWHOUSE, JP
    WEILER, PC
    HIATT, HH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (06) : 370 - 376
  • [3] Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
    Davies, Emma C.
    Green, Christopher F.
    Taylor, Stephen
    Williamson, Paula R.
    Mottram, David R.
    Pirmohamed, Munir
    [J]. PLOS ONE, 2009, 4 (02):
  • [4] *DTSCH KRANK SPITZ, 2005, ALLG SPEZ KOD VERSCH
  • [5] Strategies for detecting adverse drug events among older persons in the ambulatory setting
    Field, TS
    Gurwitz, JH
    Harrold, LR
    Rothschild, JM
    Debellis, K
    Seger, AC
    Fish, LS
    Garber, L
    Kelleher, M
    Bates, DW
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2004, 11 (06) : 492 - 498
  • [6] GOETTLER M, 1997, PHARMACOEPIDEMIOL S3, V6, P79
  • [7] How Often are Potential Patient Safety Events Present on Admission?
    Houchens, Robert L.
    Elixhauser, Anne
    Romano, Patrick S.
    [J]. JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2008, 34 (03) : 154 - 163
  • [8] Hospital admissions associated with adverse drug reactions: A systematic review of prospective observational studies
    Kongkaew, Chuenjid
    Noyce, Peter R.
    Ashcroft, Darren M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2008, 42 (7-8) : 1017 - 1025
  • [9] Incidence of adverse drug reactions in hospitalized patients - A meta-analysis of prospective studies
    Lazarou, J
    Pomeranz, BH
    Corey, PN
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (15): : 1200 - 1205
  • [10] Muehlberger N., 1997, Pharmacoepidemiol Drug Saf, V6, P71